Solutions...

Pricing & Access
Strategies

Optimal pricing strategies for development decisions and market access.

Read more

Conjoint
Research

Delivering conjoint that can handle the intricacies of the pharma market.

Read more

Forecasting
Software

Allowing leading pharma companies to build evidence-based forecasts fast and easily.

Read more

Launch Sequence
Simulators

Get your country launch sequence right. Capture full value in the face of international reference pricing.

Read more

Training
Courses

Industry-leading pricing-for-market-access and forecasting training.

Read more

Case Studies

See how Inpharmation propels clients to the next level

Explore our case studies.
Ask what we can do for you.

View

How our client got reliable price and value driver insights from payers in a rare neurology indication

Our client needed value drivers and market shares in the complex multiple myeloma market. They suspected that their situation was too complex for conjoint because:

Read Case Study

How optimizing the second wave of country launches increased a brand’s revenue by ~1.4 million euros

Our client wanted to optimize the launch sequence of 40 “second-wave” countries. Our biotech client came to us for help in optimizing a country launch sequence. This was not something…

Read Case Study

How our client got powerful results in a market they thought was too complex for conjoint

Payer interviews wouldn’t give the quantitative insights our client needed. Our client had already run qualitative research with payers, sothey knew what was important to payers. But they wanted to…

Read Case Study

Delivering an ultra-rare gene therapy pricing strategy where payer interviews failed

A model-based pricing and market access approach gave answers where payers couldn’t Our client, a specialty pharmaceutical company, was developing a novel gene therapy to treat an ultra-rare disease. Payer…

Read Case Study

We tailor our services to your exact requirements

Get in touch with us and arrange a meeting